低氧预处理通过激活低氧诱导因子1α增强老年人骨髓间充质干细胞促血管新生能力#br#

#br#

宋慧芳 谈佳音 刘阳 张卫国 郭蕊

解剖学报 ›› 2022, Vol. 53 ›› Issue (1) : 35-41.

PDF(9515 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(9515 KB)
解剖学报 ›› 2022, Vol. 53 ›› Issue (1) : 35-41. DOI: 10.16098/j.issn.0529-1356.2022.01.005

低氧预处理通过激活低氧诱导因子1α增强老年人骨髓间充质干细胞促血管新生能力#br#

#br#

  • 宋慧芳1,2* 谈佳音2 刘阳2 张卫国2 郭蕊3*
作者信息 +

Hypoxic pretreatment enhancing the angiogenesis of aged human bone marrow mesenchymal stem cells through hypoxia inducible factor-1α

  • SONG Hui-fang1,2* TAN Jia-yin LIU Yang ZHANG Wei-guo2  GUO Rui3*
Author information +
文章历史 +

摘要

目的  探讨低氧预处理对老年人骨髓间充质干细胞(hBMSCs)促血管新生能力的影响,为改善老年患者自体干细胞移植治疗缺血性心肌损伤疗效提供支持。   方法  老年hBMSCs经过低氧预处理后,倒置相差显微镜下摄片观察细胞形态,流式细胞术检测细胞表面标志物,并进行成骨、成脂诱导分化检测其分化潜能。随后收集青年hBMSCs常氧培养基(norCM),老年hBMSCs常氧和低氧培养基(hypoCM),分别为norCM-young、norCM-old和hypoCM-old 3组条件培养基,未加干细胞的等体积培养基为阴性对照(control)组。各组条件培养基分别处理人脐静脉内皮细胞(HUVECs),用CCK-8法检测细胞存活率,用管状结构形成实验检测体外血管新生能力。BCA法检测各组条件培养基总蛋白含量,Western blotting技术检测细胞中及条件培养基中低氧诱导因子1α(HIF-1α)含量。   结果  低氧预处理对老年hBMSCs形态、表面标志物及分化潜能影响不显著(P>0.05,n≥3)。HypoCM-old组与norCM-old组相比,低氧-复氧培养条件下HUVECs的存活率显著提高(P<0.05,n=5), HUVECs细胞管状结构形成能力也显著提高(P<0.01,n=5)。HypoCM-old组总蛋白量显著高于norCM-old组(P<0.05,n=3),hypoCM-old组 hBMSCs中HIF-1α表达量显著高于norCM-old 组(P<0.05,n=3),同时hypoCM-old组培养基中HIF-1α的含量显著高于norCM-old组(P<0.01,n=3)。   结论  低氧预处理的老年hBMSCs通过旁分泌促进体外HUVECs存活和管状结构的形成,而其促进作用与HIF-1α的活化相关。 

Abstract

Objective  To investigate the effect of hypoxic pretreatment on the angiogenesis of aged human bone marrow mesenchymal stem cells (hBMSCs),  so to provide experimental support for more effective autologous stem cell transplantation therapy in aged patients with ischemic myocardial injury.    Methods  The aged hBMSCs were cultured in a hypoxic incubator, and then the cell morphology  was observed under inverted phase-contrast microscope, the surface markers were detected by flow cytometry, and the differentiation potential was detected by osteogenic and adipogenic differentiation. Subsequently, the conditioned medium(CM) of young hBMSCs under normoxic culture (norCM), the conditioned media of aged hBMSCs under normoxic and hypoxic culture(hypoCM) were collected respectively. They were named as norCM-young, norCM-old and hypoCM-old. The equal volume of medium, which was not treated with stem cells, was set as control group. Human umbilical vein endothelial cells (HUVECs) were treated with 4 conditioned media, the cell survival rate was detected by CCK-8 assay, and the tube formation experiment was used to detect the angiogenesis ability in vitro. The BCA method  was used to detect the total protein concentration of the conditioned medium of each group, and the Western blotting was used to detect  the expression of hypoxia inducible factor-1α (HIF-1α) in the cells and the conditioned media.    Results  There was not significant effect of hypoxic pretreatment on the morphology, surface markers and differentiation ability of aged hBMSCs (P>0.05. n≥3). Compared with the norCM-old group, hypoCM-old group significantly improved the survival of HUVECs under hypoxia-reoxygenation condition (P<0.05, n=5), and the tube formation ability of it (P<0.01, n=5). The total protein concentration of hypoCM-old group was significantly higher than that of norCM-old group (P<0.05, n=3). The expression of HIF-1α in hBMSCs of hypo-old group was significantly higher than that of nor-old group (P<0.05,n=3), while the content of HIF-1α in conditioned medium of hypoCM-old group was significantly higher than that in norCM-old group (P<0.01,n=3).    Conclusion  The aged hBMSCs pretreated with hypoxia can promote the survival and tube formation of HUVECs through paracrine in vitro, which is HIF-1α-related.

关键词

低氧预处理 / 低氧诱导因子1α / 老龄 / 骨髓间充质干细胞 / 血管新生 / 免疫印迹法 / 人 

Key words

Hypoxic preconditioning / Hypoxia inducible factor-1α / Ageing / Bone marrow mesenchymal stem cells / Angiogenesis / Western blotting / human


引用本文

导出引用
宋慧芳 谈佳音 刘阳 张卫国 郭蕊. 低氧预处理通过激活低氧诱导因子1α增强老年人骨髓间充质干细胞促血管新生能力#br#
#br#
[J]. 解剖学报. 2022, 53(1): 35-41 https://doi.org/10.16098/j.issn.0529-1356.2022.01.005
SONG Hui-fang TAN Jia-yin LIU Yang ZHANG Wei-guo GUO Rui. Hypoxic pretreatment enhancing the angiogenesis of aged human bone marrow mesenchymal stem cells through hypoxia inducible factor-1α[J]. Acta Anatomica Sinica. 2022, 53(1): 35-41 https://doi.org/10.16098/j.issn.0529-1356.2022.01.005
中图分类号: R322    

参考文献

[1] Virani SS, Alonso A, Benjamin EJ, et al.Heart disease and stroke statistics-2020 update: a report from the american heart association[J]. Circulation, 2020,141(9): e139-e596.  
[2] China cardiovascular health and disease report writing group. 2019 summary of China cardiovascular health and disease report[J].Chinese Circulation Journal, 2020, 35(9): 833-854.(in Chinese) 
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志, 2020, 35(9): 833-854.
[3] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158. 
[4] Mathew SA, Naik C, Cahill PA, et al. Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis[J]. Cell Mol Life Sci,2020,77(2):253-265. 
[5] Bosch-Marce M,Okuyama H,Wesley JB,et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia[J]. Circ Res, 2007, 101(12): 1310-1318. 
[6] Russo V, Young S, Hamilton A, et al. Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury[J]. Biomaterials, 2014, 35(13): 3956-3974. 
[7] Bianconi V, Sahebkar A, Kovanen P, et al. Endothelial and cardiac progenitor cells for cardiovascular repair:controversial paradigm in cell therapy[J]. Pharmacol Ther, 2018, 181:156-168. 
[8] Li SH, Sun Z, Brunt KR, et al. Reconstitution of aged bone marrow with young cells repopulates cardiac-resident bone marrow-derived progenitor cells and prevents cardiac dysfunction after a myocardial infarction[J]. Eur Heart J, 2013, 34(15): 1157-1167. 
[9] Li XQ, Bai ShL,Ao Q,et al. Effects of Klotho on the proliferation and differentiation of rat bone marrow mesenchymal stem cells[J].Acta Anatomica Sinica, 2019,50(6):729-734.(in Chinese) 
李秀全,柏树令,敖强,等. Klotho对大鼠骨髓间充质干细胞增殖和分化的影响[J]. 解剖学报, 2019,50(6):729-734.
[10] Li Q,Zhu Z,Wang C,et al. CTRP9 ameliorates cellular senescence via PGC1α/AMPK signaling in mesenchymal stem cells[J]. Int J Mol Med, 201,42(2):1054-1063. 
[11] Liang C,Liu Z,Song M,et al. Stabilization of heterochromatin by CLOCK promotes stem cell rejuvenation and cartilage regeneration[J]. Cell Res,2021,31(2): 187-205. 
[12] Bi S,Wang H,Kuang W. Stem cell rejuvenation and the role of autophagy in age retardation by caloric restriction: an update[J]. Mech Ageing Dev,2018,175:46-54. 
[13] Song HF,Guo R,Zhang L. Hypoxic preconditioning increases tolerant ability of old human bone marrow mesenchymal stem cells to oxidative stress injury through AKT pathway[J].Chinese Journal of Pathophysiology, 2016,32(5):912-916. (in Chinese) 
宋慧芳,郭蕊,张亮. 低氧预处理通过激活AKT通路提高老年hBMMSCs对氧化应激损伤的耐受能力[J]. 中国病理生理杂志,2016,32(5):912-916
[14] Choi SH,Shin HW,Park JY,et al. Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines[J]. Korean J Hepatol,2010,16(3): 280-287. 
[15] Yu X,Gao C,Dai C,et al. Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure[J]. Reprod Biomed Online,2019,38(5): 761-767. 
[16] Song HF, He S, Li SH, et al. Aged human multipotent mesenchymal stromal cells can be rejuvenated by neuron-derived neurotrophic factor and improve heart function after Injury[J]. JACC Basic Transl Sci, 2017,2(6):702-716. 
[17] Jia SD,Yao Y,Song Y, et al. Two-year outcomes after left main coronary artery percutaneous coronary intervention in patients presenting with acute coronary syndrome[J]. J Interv Cardiol,2020,2020:6980324. 
[18] Chen Z, Chen L, Zeng C, et al. Functionally improved mesenchymal stem cells to better treat myocardial infarction[J]. Stem Cells Int,2018,2018:7045245. 
[19] Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease[J]. Circ Res,2011,109(8):923-940. 
[20] Nurkovic J, Volarevic Ⅴ, Lako M, et al. Aging of stem and progenitor cells: mechanisms, impact on therapeutic potential, and rejuvenation[J]. Rejuvenation Res,2016,19(1):3-12.  
[21] Khorraminejad-Shirazi M, Farahmandnia M, Kardeh B, et al.Aging and stem cell therapy: AMPK as an applicable pharmacological target for rejuvenation of aged stem cells and achieving higher efficacy in stem cell therapy[J]. Hematol Oncol Stem Cell Ther, 2018,11(4):189-194. 
[22] Tekin D, Dursun AD, Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection[J]. Acta Pharmacol Sin, 2010,31(9):1085-1094. 
[23] Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury[J]. Circulation,2003,108(1):79-85. 
[24] Cao R, Br?kenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2[J]. Nat Med,2003,9(5):604-613. 
[25] Hou J, Wang L, Long H, et al. Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis[J]. Stem Cell Res Ther, 2017,8(1):215.

基金

NDNF在老年间充质干细胞年轻化和治疗缺血性心肌损伤中的作用及机制研究;NDNF通过促进血管新生改善干细胞移植治疗缺血性心肌损伤的作用及机制研究;尼古丁致血管动脉粥样硬化新机制-窖蛋白-1的多重调节作用

PDF(9515 KB)

Accesses

Citation

Detail

段落导航
相关文章

/